During continuous ambulatory peritoneal dialysis (CAPD), the loss of complement factors via the dialysate may cause complement deficiencies. This hypothesis was tested in a group of children treated with CAPD.
Design
Classical (CH50) and alternative (AP50) complement activity and serum levels of factors C1 q, C3, C4, C3d, B, D, and P in CAPD patients were compared to normal controls and to children with preterminal renal failure.
Setting
Patients were seen in a university hospital; normal controls were seen in an outpatient clinic of a general hospital.
Patients
A group of 22 children on CAPD was compared to a normal control group of 44 children and to a group of 12 children with preterminal renal failure with a creatinine clearance below 25 mL/min/1.73 m2.
Results
CH50, AP50, C3, and B were not significantly different from the control group in both the CAPD and preterminal groups. Factors C1q (p=0.01) and C4, C3d, D, and P (p<0.001) were higher in the CAPD group in comparison to the normal control group. The factors D (p<0.001) and P (p=0.02) were also elevated in the preterminal group. For the measured factors there was no significant difference between the CAPD group and the preterminal group.
Conclusions
There is no deficiency of complement in children treated with CAPD. High levels of C3d and D can be explained by the reduction of their elimination by the kidney. The increased levels of the other factors are presumably due to increased synthesis in renal failure. This does not seem to be caused by CAPD.
McLeanR.H., ForsgrenA., BjörksténB., KimY., QuieP.G., MichaelA.F.Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome.Pediatr Res1977; 11: 910–6.
2.
KredietR.T., AsgharS.S., KoomenG.C.M., VennekerG.T., StruijkD.G., AriszL.Effects of renal failure on complement C3d levels.Nephron1991; 59: 41–5.
3.
PascualM., SteigerG., EstreicherJ., MaconK., VolanakisJ.E., SchifferliJ.A.Metabolism of complement factor D in renal failure.Kidney Int1988; 34: 52936.
4.
GordonD.L., RiceJ.L., AveryV.M.Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.Eur J Clin Microbiol Infect Dis1990; 9: 191–7.
5.
McGregorS.J., BrockJ.H., BriggsJ.D., JunorB.J.R.Lon-gitudinal study of peritoneal defense mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1989; 9: 115–9.
6.
McGregorS.J., BrockJ.H., BriggsJ.D., JunorB.J.R.Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.Nephrol Dial Transplant1987; 2: 551–6.
7.
HiemstraP.S., LangelerE., CompierB.Complete and partial deficiencies of complement factor D in a Dutch family.J Clin Invest1989; 84: 1957–61.
8.
MayerM.M.Complement versus complement fixation. In: KabatE.A., MayerM.M., eds. Experimental immunochemistry.Springfield: CC Thomas, 1961: 133–240.
9.
DahaM.R., van EsL.A.Enhanced alternative pathway dependent degradation of soluble immunoglobulin aggregates by macrophages.Immunology1981; 43: 513–8.
10.
FineR.N., Saluskyill, HallT., LuculloL., JordanS.C., EttengerR.B.Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.Pediatrics1983; 71: 806–9.
11.
LevyM., BalfeJ.W., GearyD.F., Fryer-KeeneS.P., BannatyneR.M.Peritonitis in children undergoing dialysis. 10 years’ experience.Child Nephrol Urol1988-89; 9: 253–8.
12.
MocanH., MurphyA.V., BeattieT.J., McAllisterT.A.Peritonitis in children on continuous ambulatory peritoneal dialysis.J Infect1988; 16: 243–51.
13.
PowellD., LuisE.S., CalvinS., McDaidT., PotterD.Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.Am J Dis Child1985; 139: 29–32.
14.
AlobaidiH.M., ColesG.A., DaviesM., LloydD.Host defence in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function.Nephrol Dial Transplant1986; 1: 16–21.
15.
ReadR.R., EberweinP., DasguptaM.K.Peritonitis in peritoneal dialysis: Bacterial colonization by biofilm spread along the catheter surface.Kidney Int1989; 35: 614–21.
16.
TranæusA., HeimbürgerO., LindholmB.Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): Risk factors, clinical severity, and pathogenetic aspects.Perit Dial Int1988; 8: 253–63.
17.
ZimmermanS.W., O'BrienM., WiedenhoeftF.A., JohnsonC.A.Staphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitis.Perit Dial Int1988; 8: 191–4.
18.
McGregorS.J., BrockJ.H., BriggsJ.D., JunorB.J.R.Bactericidal activity of peritoneal macrophages from continuous ambulatory peritoneal dialysis patients.Nephrol Dial Transplant1987; 2: 104–8.
BlumenkrantzM.J., GahlG.M., KoppleJ.D.Protein losses during peritoneal dialysis.Kidney Int1981; 19: 593–602.
21.
KatirtzoglouA., OreopoulosD.G., HusdanH., LeungM., OgilvieR., DombrosN.Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis.Nephron1980; 26: 230–3.
22.
KaganA., Bar-KhayimY., SchaferZ., FainaruM.Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins.Kidney Int1990; 37: 971–9.
23.
KredietR.T., KoomenG.C.M., KoopmanM.G.The peritoneal transport of serum proteins and neutral dextran in CAPD patients.Kidney Int1989; 35: 1064–72.
24.
ScarpioniL.L., PoisettiP.G., BallochiS., BergonziG.Selective peritoneal protein loss.Contrib Nephrol1989; 70: 318–24.
25.
RubinJ., NolphK.D., ArfaniaD.Protein losses in continuous peritoneal dialysis.Nephron1981; 28: 218–21.
YoungG.A., TaylorA., KendallS., BrownjohnA.M.Longi-tudinal study of proteins in plasma and dialysate during continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1990; 10: 257–61.
28.
SchröderC.H., BakkerenA.J.M., WeemaesC.M.R., MonnensL.A.H.IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis.Perit Dial Int1989; 9: 261–5.
29.
MaackT., JohnsonV., KauS.T., FigueiredoJ., SigulemD.Renal filtration, transport, and metabolism of low molecular weight proteins: A review.Kidney Int1979; 16: 251–70.
30.
VolanakisJ.E., BarnumS.R., GiddensM., GallaJ.H.Renal filtration and catabolism of complement protein D.New Engl J Med1985; 312: 395–9.
31.
CatanaE., SchifferliJ.A.Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis.J Immunol Methods1991; 138: 265–71.
32.
PascualM., PaccaudJ.P., MaconK., VolanakisJ.E., SchifferliJ.A.Complement activation by the alternative pathway is modified in renal failure: The role of factor D.Clin Nephrol1989; 32: 185–93.
33.
MiyataT., InagiR., HongK.Fluid-phase activation of the alternative pathway of complement by excess factor D in regularly dialyzed patients.Nephron1992; 60: 144–9.
34.
ten DamM.A.G.J., ten KateR.W., WerterC.J.P.J., van KampG.J., MeuwissenS.G.M., DonkerA.J.M.Measurement of the glomerular sieving coefficient of endogenous proteins in man.Contrib Nephrol1990; 83: 47–52.
35.
LewisS.L., Van EppsD.E., ChenowethD.E.C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients.Clin Nephrol1986; 26: 37–44.
36.
HolmesC.J., LewisS.L., EvansR.C., KubeyW.Y., LuneburgP., MuchaD.Periodic elevation of complement activation products in peritoneal dialysis effluent.ASAIO Trans1989; 35: 587–9.
